| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.79B | 11.55B | 8.42B | 7.89B | 6.86B | 7.65B |
| Gross Profit | 5.57B | 4.52B | 3.24B | 2.66B | 2.69B | 3.62B |
| EBITDA | 3.72B | 4.03B | 2.69B | 2.23B | 1.73B | 2.89B |
| Net Income | 2.46B | 1.45B | 686.43M | 401.95M | 33.70M | 1.05B |
Balance Sheet | ||||||
| Total Assets | 58.27B | 53.57B | 46.87B | 45.89B | 43.02B | 39.69B |
| Cash, Cash Equivalents and Short-Term Investments | 5.51B | 3.59B | 4.44B | 5.11B | 4.24B | 2.86B |
| Total Debt | 20.44B | 20.05B | 17.79B | 18.81B | 16.91B | 17.45B |
| Total Liabilities | 30.68B | 28.38B | 24.62B | 25.84B | 23.29B | 22.63B |
| Stockholders Equity | 23.47B | 21.18B | 18.86B | 16.61B | 16.30B | 13.55B |
Cash Flow | ||||||
| Free Cash Flow | 2.54B | 318.48M | 283.10M | -768.09M | 419.97M | 2.21B |
| Operating Cash Flow | 4.11B | 2.38B | 1.83B | 692.97M | 2.80B | 3.63B |
| Investing Cash Flow | -1.96B | -6.35B | -1.96B | -1.96B | -2.88B | -1.94B |
| Financing Cash Flow | -1.85B | 3.11B | -551.68M | 1.83B | 1.24B | -3.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$16.37B | 14.89 | 23.61% | 0.44% | 6.76% | 239.14% | |
66 Neutral | HK$978.78B | 16.09 | 30.60% | 1.55% | 9.69% | 54.43% | |
66 Neutral | HK$36.89B | 13.75 | 33.81% | 1.40% | 70.92% | 249.45% | |
64 Neutral | HK$115.06B | 27.53 | 11.01% | 0.16% | 44.37% | 125.87% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | HK$198.44B | 33.06 | ― | 0.93% | 36.74% | 36.49% | |
40 Underperform | HK$834.97M | -31.17 | -1.02% | ― | ― | -25.51% |